Community-acquired Pneumonia and Hospital-acquired Pneumonia

Med Clin North Am. 2019 May;103(3):487-501. doi: 10.1016/j.mcna.2018.12.008. Epub 2019 Mar 7.

Abstract

Pneumonia is among the leading causes of morbidity and mortality worldwide. Although Streptococcus pneumoniae is the most likely cause in most cases, the variety of potential pathogens can make choosing a management strategy a complex endeavor. The setting in which pneumonia is acquired heavily influences diagnostic and therapeutic choices. Because the causative organism is typically unknown early on, timely administration of empiric antibiotics is a cornerstone of pneumonia management. Disease severity and rates of antibiotic resistance should be carefully considered when choosing an empiric regimen. When complications arise, further work-up and consultation with a pulmonary specialist may be necessary.

Keywords: CAP; Community-acquired pneumonia; HAP; Hospital-acquired pneumonia; Pneumonia.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Community-Acquired Infections / diagnosis*
  • Community-Acquired Infections / microbiology
  • Community-Acquired Infections / physiopathology
  • Community-Acquired Infections / therapy*
  • Healthcare-Associated Pneumonia / diagnosis
  • Healthcare-Associated Pneumonia / microbiology
  • Healthcare-Associated Pneumonia / physiopathology
  • Healthcare-Associated Pneumonia / therapy
  • Humans
  • Pneumonia / diagnosis*
  • Pneumonia / microbiology
  • Pneumonia / physiopathology
  • Pneumonia / therapy*
  • Risk Factors

Substances

  • Anti-Bacterial Agents